Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: Apr 9, 2020

Total Value: $383M (100.0% shares, 0.0% debt)

Holdings (39)

ASND ASCENDIS PHARMA A S 11.8%
Value $45.31M Shares 385,000 Share Price $117.70 Est. Cost/Share $95.44 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 6.3%
Value $24.16M Shares 900,000 Share Price $26.85 * Est. Cost/Share $23.61 Unrealized @ Report Date -1.1%
ASND ASCENDIS PHARMA A S 5.7%
Value $21.77M Shares 185,000 Share Price $117.70 Est. Cost/Share $95.44 Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 5.0%
Value $19.21M Shares 240,000 Share Price $80.05 Est. Cost/Share $80.05 Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 4.6%
Value $17.68M Shares 1,300,000 Share Price $13.60 * Est. Cost/Share $11.60 Unrealized @ Report Date +5.3%
— GLOBAL BLOOD THERAPEUTICS IN 4.1%
Value $15.88M Shares 300,000 Share Price $52.93 Est. Cost/Share $49.14 Unrealized @ Report Date —
— IMMUNOMEDICS INC 4.0%
Value $15.37M Shares 800,000 Share Price $19.21 Est. Cost/Share $8.35 Unrealized @ Report Date —
VRTX VERTEX PHARMACEUTICALS INC 3.8%
Value $14.72M Shares 80,000 Share Price $183.95 Est. Cost/Share $173.27 Unrealized @ Report Date +6.6%
ALNY ALNYLAM PHARMACEUTICALS INC 3.7%
Value $14.02M Shares 150,000 Share Price $93.45 * Est. Cost/Share $87.26 Unrealized @ Report Date -4.2%
— SAGE THERAPEUTICS INC 3.1%
Value $11.93M Shares 75,000 Share Price $159.05 Est. Cost/Share $158.27 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 3.0%
Value $11.45M Shares 400,000 Share Price $28.62 * Est. Cost/Share $16.62 Unrealized @ Report Date +30.5%
— RETROPHIN INC 3.0%
Value $11.31M Shares 500,000 Share Price $22.63 Est. Cost/Share $26.90 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 2.9%
Value $10.99M Shares 150,000 Share Price $73.30 Est. Cost/Share $33.00 Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 2.9%
Value $10.94M Shares 1,150,000 Share Price $9.51 * Est. Cost/Share $9.65 Unrealized @ Report Date +0.6%
RCKT ROCKET PHARMACEUTICALS INC 2.7%
Value $10.52M Shares 600,000 Share Price $17.54 * Est. Cost/Share $16.85 Unrealized @ Report Date -6.3%
— CYMABAY THERAPEUTICS INC 2.6%
Value $9.96M Shares 750,000 Share Price $13.28 Est. Cost/Share $13.28 Unrealized @ Report Date —
— BIOHAVEN PHARMACTL HLDG CO L 2.4%
Value $9.007M Shares 175,000 Share Price $51.47 Est. Cost/Share $37.40 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 2.3%
Value $8.799M Shares 700,000 Share Price $12.57 * Est. Cost/Share $8.83 Unrealized @ Report Date 0.0%
FXF INVESCO CURNCYSHS SWISS FRAN 2.2%
Value $8.574M Shares 91,800 Share Price $93.40 Est. Cost/Share $94.55 Unrealized @ Report Date —
ANAB ANAPTYSBIO INC 2.2%
Value $8.401M Shares 115,000 Share Price $73.05 * Est. Cost/Share $80.01 Unrealized @ Report Date -13.7%
— MOMENTA PHARMACEUTICALS INC 1.9%
Value $7.265M Shares 500,000 Share Price $14.53 Est. Cost/Share $12.26 Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 1.8%
Value $6.829M Shares 175,000 Share Price $39.02 Est. Cost/Share $21.32 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 1.8%
Value $6.72M Shares 300,000 Share Price $22.40 Est. Cost/Share $22.40 Unrealized @ Report Date —
— DBV TECHNOLOGIES S A 1.7%
Value $6.554M Shares 850,000 Share Price $7.71 Est. Cost/Share $7.71 Unrealized @ Report Date —
— EPIZYME INC 1.6%
Value $6.195M Shares 500,000 Share Price $12.39 Est. Cost/Share $12.39 Unrealized @ Report Date —
CHRS COHERUS BIOSCIENCES INC 1.6%
Value $6.138M Shares 450,000 Share Price $13.64 * Est. Cost/Share $13.34 Unrealized @ Report Date 0.0%
— TRICIDA INC 1.5%
Value $5.793M Shares 150,000 Share Price $38.62 Est. Cost/Share $30.07 Unrealized @ Report Date —
— KADMON HLDGS INC 1.4%
Value $5.544M Shares 2,100,000 Share Price $2.64 Est. Cost/Share $3.79 Unrealized @ Report Date —
VRAYQ VIEWRAY INC 1.4%
Value $5.543M Shares 750,000 Share Price $7.39 * Est. Cost/Share $6.99 Unrealized @ Report Date +10.4%
— ORCHARD THERAPEUTICS PLC 1.4%
Value $5.364M Shares 300,000 Share Price $17.88 Est. Cost/Share $15.73 Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 1.2%
Value $4.411M Shares 310,000 Share Price $14.23 * Est. Cost/Share $9.29 Unrealized @ Report Date 0.0%
BCRX BIOCRYST PHARMACEUTICALS 1.1%
Value $4.07M Shares 500,000 Share Price $8.14 * Est. Cost/Share $6.72 Unrealized @ Report Date +27.5%
— CHIASMA INC 1.0%
Value $3.64M Shares 700,000 Share Price $5.20 Est. Cost/Share $5.20 Unrealized @ Report Date —
ARVN ARVINAS INC 0.7%
Value $2.583M Shares 175,000 Share Price $14.76 * Est. Cost/Share $16.46 Unrealized @ Report Date +7.8%
— OBSEVA SA 0.7%
Value $2.558M Shares 200,000 Share Price $12.79 Est. Cost/Share $11.87 Unrealized @ Report Date —
— GENOCEA BIOSCIENCES INC 0.3%
Value $1.18M Shares 2,000,000 Share Price $0.59 Est. Cost/Share $0.86 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 0.2%
Value $920K Shares 100,000 Share Price $9.20 Est. Cost/Share $9.20 Unrealized @ Report Date —
— CATALYST BIOSCIENCES INC 0.2%
Value $811K Shares 100,000 Share Price $8.11 Est. Cost/Share $25.80 Unrealized @ Report Date —
— FIBROGEN INC 0.2%
Value $625K Shares 11,500 Share Price $54.35 Est. Cost/Share $54.35 Unrealized @ Report Date —